• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Here's How Innovation Can Drive Apple Higher

The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.
By ED PONSI
Mar 07, 2023 | 10:30 AM EST
Stocks quotes in this article: AAPL

On Monday, Goldman Sachs initiated coverage of Apple (AAPL) with a buy rating and a price target of $199. The investment bank's analyst, Michael Ng, focused on Apple's huge customer base and ecosystem as an engine of growth.

Ng believes Apple's high degree of brand loyalty among consumers, combined with continued growth in services, should offset any potential slowdown in sales of iPhones and other products.

Do Apple's technicals agree with Goldman Sachs' analysis? Let's go to the charts to find out.

Over the past three months, Apple has formed a cup-and-handle pattern (black curved lines). This bullish formation projects the stock to the $185 area.

Source: TradeStation

Apple is trading above its 50-day (blue) and 200-day (red) moving averages. The 50-day MA is rising, increasing the potential for a bullish moving average crossover.

On Monday, Apple's volume reached its highest level in over a month (black arrow), but the stock hasn't broken out yet. The stock needs a catalyst to push it above $157 (green dotted line), a price Apple has failed to surpass on several occasions (green arrows).

Regarding the Goldman Sachs upgrade, Ng isn't wrong about Apple's customer base and ecosystem, but there might be more to this story.

Apple is known for innovation. Nearly six years ago, I wrote about what I believe could become the company's greatest innovation.

In 2017, reports were circulating that Apple was hiring biomedical engineers with a goal to develop sensors that could monitor blood sugar levels without piercing skin. Eventually, the sensors could be combined with Apple's Watch or used to create a separate wearable medical device.

After years of silence, reports are again circulating about the project. It's now reported that Apple has made significant progress but still has work to do before a wearable glucose monitor can become a reality.

Why is this project so important? According to the Centers for Disease Control, 37.3 million Americans, or about one in 10, have diabetes. That figure jumps globally to 422 million, according to the World Health Organization. About 1.5 million deaths per year are directly attributed to diabetes.

A wearable blood monitoring device would dramatically widen Apple's already formidable user base. If this project comes to fruition and just part of its potential is realized, lives will be changed for the better and Apple shareholders will benefit for years to come.

(AAPL is a holding of Action Alerts PLUS. Want to be alerted before the portfolio buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Ponsi was long AAPL.

TAGS: Investing | Stocks | Fundamental Analysis | Technical Analysis | Health Care Equipment & Services | Healthcare | Technology | Technology Hardware & Equipment | Real Money | Analyst Actions

More from Stocks

The Chasing Slows on Wall Street

James "Rev Shark" DePorre
Mar 24, 2023 4:34 PM EDT

After Deutsche Bank shakes up investors, market cools a bit, which might be a healthy development.

Stay Away From These Types of Stocks, They're Radioactive

Jim Collins
Mar 24, 2023 2:35 PM EDT

Here's what you're better off buying. I certainly have.

GE Looks Poised for a Pullback: How to Trade It Now

Bruce Kamich
Mar 24, 2023 1:45 PM EDT

The shares stopped short of my price targets.

It's Not Whether the Next Shoe Will Drop, But Where and When

Bret Jensen
Mar 24, 2023 11:30 AM EDT

A few months of anxiety likely lies ahead of us, and caution remains the watchword of the day.

The Good, Bad and Ugly: What's Happening and What Investors Need to Do

Stephen Guilfoyle
Mar 24, 2023 10:45 AM EDT

Right now I have more in cash, or equivalents, than in equities. Ever hear of a Wall Street guy saying that before?

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • 08:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How to Adjust Your Trading Style as Market Conditi...
  • 05:00 PM EDT CHRIS VERSACE

    AAP Podcast on the Fed Decision!

    Listen here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login